Search Results - "van der Stok, E P"

Prognostic Value of Body Mass Index on Short-Term and Long-Term Outcome after Resection of Esophageal Cancer by Grotenhuis, B. A., Wijnhoven, B. P. L., Hötte, G. J., van der Stok, E. P., Tilanus, H. W., van Lanschot, J. J. B.

“…Introduction Cachexia and obesity have been suggested to be risk factors for postoperative complications. However, high body mass index (BMI) might result in a…”
Get full text

Systematic review of the influence of chemotherapy‐associated liver injury on outcome after partial hepatectomy for colorectal liver metastases by Zhao, J., van Mierlo, K. M. C., Gómez‐Ramírez, J., Kim, H., Pilgrim, C. H. C., Pessaux, P., Rensen, S. S., van der Stok, E. P., Schaap, F. G., Soubrane, O., Takamoto, T., Viganò, L., Winkens, B., Dejong, C. H. C., Olde Damink, S. W. M., García Sanz, I., Martín Pérez, E., Cho, J. Y., Choi, Y. R., Phillips, W., Michael, M., Panaro, F., Chenard, M.‐P., Verhoef, C., Grünhagen, D. J., Vara, J., Scatton, O., Hashimoto, T., Makuuchi, M., De Rosa, G., Ravarino, N.

“…Background The impact of chemotherapy‐associated liver injury (CALI) on postoperative outcome in patients undergoing partial hepatectomy for colorectal liver…”
Get full text

The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy by Filipe, W. F., Meyer, Y. M., Buisman, F. E., van den Braak, R. R. J. Coebergh, Galjart, B., Höppener, D. J., Jarnagin, W. R., Kemeny, N. E., Kingham, T. P., Nierop, P. M. H., van der Stok, E. P., Grünhagen, D. J., Vermeulen, P. B., Groot Koerkamp, B., Verhoef, C., D’Angelica, M. I.

“…Background Histopathological growth patterns (HGPs) are a prognostic biomarker in colorectal liver metastases (CRLM). Desmoplastic HGP (dHGP) is associated…”
Get full text

Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue by Lysaght, J, van der Stok, E.P, Allott, E.H, Casey, R, Donohoe, C.L, Howard, J.M, McGarrigle, S.A, Ravi, N, Reynolds, J.V, Pidgeon, G.P

“…Highlights ► Visceral fat has significantly higher VEGF, CD8+ and NKT cells than subcutaneous fat. ► VEGF levels in serum and vACM is significantly higher in…”
Get full text

Regional and inter-hospital differences in the utilisation of liver surgery for patients with synchronous colorectal liver metastases in the Netherlands by t Lam-Boer, J, van der Stok, E.P, Huiskens, J, Verhoeven, R.H.A, Punt, C.J.A, Elferink, M.A.G, de Wilt, J.H, Verhoef, C

“…Abstract Background The objective of this study was to map referral patterns in patients with synchronous colorectal liver metastases (SCLM) and to investigate…”
Get full text

The Prognostic Value of Post-operative Serum C-reactive Protein Level for Survival after Surgery for Colorectal Liver Metastases by Stok, E. P. van der, Grunhagen, D. J., Rothbarth, J., Verhoef, C.

“…Background : Increasing emphasis is put on the concept that inflammation is a key player in tumor progression. In the tumor microenvironment, inflammatory…”
Get full text

The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator by Ayez, N, van der Stok, E.P, Grünhagen, D.J, Rothbarth, J, van Meerten, E, Eggermont, A.M, Verhoef, C

“…Abstract Aim The combination of surgery and chemotherapy (CTx) is increasingly accepted as an effective treatment for patients with colorectal liver metastases…”
Get full text

Short term and long term results of patients with colorectal liver metastases undergoing surgery with or without radiofrequency ablation by van Amerongen, M.J, van der Stok, E.P, Fütterer, J.J, Jenniskens, S.F.M, Moelker, A, Grünhagen, D.J, Verhoef, C, de Wilt, J.H.W

“…Abstract Purpose The combination of resection and radiofrequency ablation (RFA) may provide an alternative treatment for patients with unresectable colorectal…”
Get full text

Results after simultaneous surgery and RFA liver ablation for patients with colorectal carcinoma and synchronous liver metastases by van Amerongen, M.J., van der Stok, E.P., Fütterer, J.J., Jenniskens, S.F.M., Moelker, A., Verhoef, C., Grünhagen, D.J., de Wilt, J.H.W.

“…Approximately 20% of patients with colorectal cancer present with synchronous liver metastases (sCRLM). These patients can be treated with a “one-step…”
Get full text

Vitamin B12 deficiency after esophagectomy with gastric tube reconstruction for esophageal cancer by van Hagen, P, de Jonge, R, van Berge Henegouwen, M I, Hötte, G J, van der Stok, E P, Lindemans, J, van Lanschot, J J B, Wijnhoven, B P L

“…The aim of this study is to determine the prevalence and incidence of vitamin B12 deficiency after esophagectomy for cancer. It is unknown if patients after…”
Get full text

mRNA expression profiles of colorectal liver metastases as a novel biomarker for early recurrence after partial hepatectomy by van der Stok, E.P., Smid, M., Sieuwerts, A.M., Vermeulen, P.B., Sleijfer, S., Ayez, N., Grünhagen, D.J., Martens, J.W.M., Verhoef, C.

“…Identification of specific risk groups for recurrence after surgery for isolated colorectal liver metastases (CRLM) remains challenging due to the…”
Get full text

The learning curve of transanal total mesorectal excision for rectal cancer is associated with local recurrence: results from a multicentre external audit by Van Oostendorp, Stefan E., Belgers, H. J. (Eric), Hol, Jeroen C., Doornebosch, Pascal G., Belt, Eric J. Th, Oosterling, Steven J., Kusters, Miranda, Bonjer, H. J. (Jaap), Sietses, Colin, Tuynman, Jurriaan B., Boerma, E. J., Creemers, D., Graaf, E. J. De, van der Hoeven, J. A. B., Sosef, M. N., Stockmann, H. B. A. C., van der Stok, E. P., Vuylsteke, R. C. L. M.

“…Aim Transanal total mesorectal excision (TaTME) has been suggested as a potential solution for the resection of challenging mid and low rectal cancer. This…”
Get full text

669TiPThe ORCHESTRA trial; A phase III trial of adding tumour debulking to systemic therapy versus systemic therapy alone in multi-organ metastatic colorectal cancer (mCRC) by Bakkerus, L, Gootjes, E C, van der Stok, E P, Buffart, T E, Zonderhuis, B M, Tuynman, J B, Meijerink, M R, van de Ven, P M, Haasbeek, C J, Tije, A J Ten, de Groot, J W, Radema, S A, Hendriks, M P, Helgason, H H, van Meerten, E, Nuyttens, J J, Grünhagen, D J, Verhoef, C, Verheul, H M W

“…Abstract Background For selected patients with oligometastatic colorectal cancer (mCRC), local treatment of metastases is standard of care based on…”
Get full text

Local approval procedures act as a brake on RCTs by van der Stok, E P, Huiskens, J, Hemmes, B, Grünhagen, D J, van Gulik, T M, Verhoef, C, Punt, C J A

“…Large multicentre randomised controlled trials (RCTs) in the Netherlands are increasingly being impeded by major differences between local approval procedures…”
Get more information